sábado, 6 de marzo de 2021

A SARS-CoV-2 spike protein adjuvant vaccine candidate produces durable rapid protection in vivo

A SARS-CoV-2 spike protein adjuvant vaccine candidate produces durable rapid protection in vivo

No hay comentarios:

Publicar un comentario